Active ingredientTemocaprilatCat. No. P-T044-001CAS 110221-53-9Family · Pharmaceutical analytical standards
Temocaprilat
The active form of temocapril, an ACE inhibitor patented in 1984 and approved in 1994, used in Japan and South Korea for hypertension and heart failure: the prodrug is converted in the body into temocaprilat, which blocks angiotensin-converting enzyme. This family brings together the active ingredient and other impurities.
Did you know?Besides the urine, it is also eliminated in the bile: this is why temocapril can be used in haemodialysis patients without a serious risk of accumulation.
Go to the active ingredient →Active ingredientTemocaprilatCat. No. P-T044-001CAS 110221-53-9
ImpurityTemocapril HydrochlorideCat. No. P-T044-003CAS 110221-44-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.